You might associate autoimmune conditions with symptoms like skin disease, chronic pain, and fatigue. A less-discussed ...

Katlyn Lenz-Zanis (left), of Burgettstown, with Dr. Jaime Miller, of Highland Park. Both women have lupus and lead Pittsburgh Lupus Support Group, a chapter of the Lupus Foundation of America.

About Enpatoran Enpatoran is a selective Toll-like receptor (TLR)7/8 inhibitor under investigation for the treatment of systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE).

Dear Editor, Hypertrophic Discoid Lupus Erythematosus (HDLE) is a unique subgroup of Cutaneous Lupus (CL) characterized by chronic, verrucous lesions that commonly affect the head and arms. It ...

However, for individuals with lupus, HRT — particularly treatments that contain estrogen — may have specific risks, such as potential disease flares and blood clots.

ORLANDO — Twice-daily deucravacitinib 3 mg and 6 mg significantly improved cutaneous lupus erythematosus activity by week 16, according to a presenter at the American Academy of Dermatology ...

Individuals with cutaneous lupus erythematosus have an increased ASCVD risk when compared with those without cutaneous lupus erythematosus.

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the CorEvitas Systemic Lupus Erythematosus Registry.

Article citations More>> Roenigk, H.H., Martin, J.S., Eichorn, P. and Gilliam, J.N. (1980) Discoid Lupus Erythematosus. Diagnostic Features and Evaluation of Topical Corticosteroid Therapy. Cutis, 25, ...

People with systemic lupus erythematosus (SLE) may experience problems with sleep. Learn what can cause sleep disturbances in lupus and how to improve sleep.

Among those with CLE, 60.7% had discoid lupus erythematosus. We found that the prevalence of ASCVD in persons with CLE was similar to that seen in SLE, and higher than that observed in persons with ...